Reporting Manager
Balyasny Asset Management L.P.
Symbol
LXEO
Shares outstanding
54,001,211 shares
Disclosed Ownership
5,394,721 shares
Ownership
10%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 06:04:07 UTC
Date of event
30 Sep 2025
Previous filing
14 Aug 2025
Next filing
17 Feb 2026

Quoteable Key Fact

"BALYASNY ASSET MANAGEMENT L.P. disclosed 10% ownership in Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share (LXEO) on 30 Sep 2025."

Quick Takeaways

  • BALYASNY ASSET MANAGEMENT L.P. filed SCHEDULE 13G/A for Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share (LXEO).
  • Disclosed ownership: 10%.
  • Date of event: 30 Sep 2025.

What Changed

  • Previous schedule filing date: 14 Aug 2025.
  • Current filing was accepted on 14 Nov 2025, 06:04.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Balyasny Asset Management L.P. 10% 5,394,721 5,394,721 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
BAM GP LLC 10% 5,394,721 5,394,721 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
Balyasny Asset Management Holdings LP 10% 5,394,721 5,394,721 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
Dames GP LLC 10% 5,394,721 5,394,721 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
Dmitry Balyasny 10% 5,394,721 5,394,721 0 /s/ Dmitry Balyasny Dmitry Balyasny / Self